Publications by authors named "Vincent Rodeschini"

Claim this Profile
I
Identification of hPIF1 helicase inhibitors by virtual screening of a Fsp3-enriched library.
Mark J A Wever, Francesca R Scommegna, Jean-François Poisson, Vincent Rodeschini, Didier Roche

Bioorg Med Chem Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055].
Birgit Caspar, Nassima Bekaddour, Séverine Grinberg, Dominique Cathelin, Ivana Stoilova, Vincent Rodeschini

Mol Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects.
Birgit Caspar, Nassima Bekaddour, Séverine Grinberg, Dominique Cathelin, Ivana Stoilova, Vincent Rodeschini

Mol Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloprotease.
Vasileios Fougiaxis, Valentina Barcherini, Milena M Petrovic, Pierre Sierocki, Sandrine Warenghem, Vincent Rodeschini

Eur J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models.
Nassima Bekaddour, Nikaïa Smith, Birgit Caspar, Severine Grinberg, Stephane Giorgiutti, Vincent Rodeschini

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design, synthesis and pharmacological characterization of novel aminopeptidase A inhibitors.
Fabrice Balavoine, Delphine Compere, Frédéric Miege, Nadia De Mota, Mathilde Keck, Vincent Rodeschini

Bioorg Med Chem Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based discovery of first inhibitors targeting the helicase activity of human PIF1.
Mark J A Wever, Francesca R Scommegna, Sara Egea-Rodriguez, Saba Dehghani-Tafti, Jose Brandao-Neto, Vincent Rodeschini

Nucleic Acids Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.
Jean-François Fournier, Laurence Clary, Sandrine Chambon, Laurence Dumais, Craig Steven Harris, Vincent Rodeschini

J Med Chem· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space.
Anne Brethon, Laurent Chantalat, Olivier Christin, Laurence Clary, Jean-François Fournier, Vincent Rodeschini

Bioorg Med Chem Lett· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action.
Amaury E Fernández-Montalván, Markus Berger, Benno Kuropka, Seong Joo Koo, Volker Badock, Vincent Rodeschini

ACS Chem Biol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the cytotoxic effects of enantiopure PPAPs, including nemorosone and clusianone.
Nigel S Simpkins, Frank Holtrup, Vincent Rodeschini, James D Taylor, Robert Wolf

Bioorg Med Chem Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of polyprenylated acylphloroglucinols using bridgehead lithiation: the total synthesis of racemic clusianone and a formal synthesis of racemic garsubellin A.
Nadia M Ahmad, Vincent Rodeschini, Nigel S Simpkins, Simon E Ward, Alexander J Blake

J Org Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic studies towards garsubellin A: synthesis of model systems and potential mimics by regioselective lithiation of bicyclo[3.3.1]nonane-2,4,9-trione derivatives from catechinic acid.
Nadia M Ahmad, Vincent Rodeschini, Nigel S Simpkins, Simon E Ward, Claire Wilson

Org Biomol Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic resolution in a bridgehead lithiation mediated by a chiral bis-lithium amide: assignment of the absolute configuration of clusianone.
Vincent Rodeschini, Nigel S Simpkins, Claire Wilson

J Org Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of (+/-)-clusianone: high-yielding bridgehead and diketone substitutions by regioselective lithiation of enol ether derivatives of bicyclo[3.3.1]nonane-2,4,9-triones.
Vincent Rodeschini, Nadia M Ahmad, Nigel S Simpkins

Org Lett· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective approaches to potential MetAP-2 reversible inhibitors.
Vincent Rodeschini, Pierre Van de Weghe, Emmanuel Salomon, Céline Tarnus, Jacques Eustache

J Org Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MetAP-2 inhibitors based on the fumagillin structure. Side-chain modification and ring-substituted analogues.
Vincent Rodeschini, Jean-Guy Boiteau, Pierre Van de Weghe, Céline Tarnus, Jacques Eustache

J Org Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis